By: Frank Angst An April 5 discussion on equine drug testing standards and practices painted a picture of underfunded industry groups and labs battling ever-growing threats. Panelists outlined those challenges at the Association of Racing Commissioners International conference on equine welfare and racing integrity in Hot Springs, Ark. Dr. Richard Sams, lab director for LGC
By: Tom Precious Trainer Roy Sedlacek was banned from all racetracks in New York for five years by regulators following what officials said was evidence two horses that ran last October at Belmont Park were administered an opioid analgesic drug nearly as potent as morphine. Sedlacek on Jan. 26 was slapped with a five-year license
By Matt Hegarty Roy Sedlacek, a New York-based trainer, has been suspended indefinitely by New York stewards after two of his horses tested positive for a powerful banned synthetic drug after racing at Belmont Park, according to state records. The two horses tested positive for a rare substance called AH-7921 while racing one week apart
Press Release LEXINGTON, KY - The Association of Racing Commissioners International (ARCI) has put all racing regulatory agencies worldwide on notice of a finding by the New York Equine Drug Testing Program of the presence of AH-7921 in post-race samples taken from horses that recently ran at Belmont Park. This is the first time AH-7921
By: Blood-Horse Staff The New York State Gaming Commission has indefinitely suspended trainer Roy Sedlacek for two positives in October at Belmont Park for AH-7921, a synthetic opioid the Association of Racing Commissioners International said can be as potent as morphine. The NYSGC scheduled a hearing on the matter for Nov. 10. Samples from Bossmon,
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
